Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Jul 18. Online ahead of print. doi: 10.1016/j.jvoice.2022.07.009

Provider and Patient Satisfaction with Telemedicine Voice Therapy During the COVID-19 Pandemic

Mary E Kim *,1, Lauren Timmons Sund *, Mariah Morton , James Kim *, Janet S Choi , M Eugenia Castro *
PMCID: PMC9289043  PMID: 36038478

Abstract

Objectives

The COVID-19 pandemic expanded the use of telemedicine, but there is no literature exploring both patient and provider satisfaction specifically in the provision of voice therapy. This study aims to investigate patient and provider satisfaction with virtual voice therapy, its associated factors, and any correlation between the two.

Methods

Cross-sectional study. Participants included 226 adults who underwent voice therapy delivered via telepractice at the USC Voice Center between April and October 2020. Patients and providers self-reported their level of satisfaction on a visual analog scale (VAS; range 0-100). Patient satisfaction was additionally measured using a previously validated Telemedicine Satisfaction Questionnaire (TSQ; range 1-5), and a binary question about their desire to choose telemedicine over in-person therapy in the future. Three speech-language pathologists rated provider satisfaction for all 226 patients. Patient satisfaction survey was completed by 55 patients. Multivariable linear regression analyses and linear mixed-effects models were used to assess the results.

Results

Patient and provider mean (SD) VAS satisfaction scores were 86.8 (18.6) and 80.6 (19.7), respectively. The mean (SD) TSQ score was 4.4 (0.6). In a multivariable model, patient satisfaction levels were significantly higher for hypofunctional than for hyperfunctional dysphonia diagnoses. Forty-four (73%) patients reported they would prefer telemedicine voice therapy over in-person appointments, which was significantly correlated with internet reliability (P = 0.04). For providers, satisfaction was significantly lower for patients whose diagnosis had changed after initiation of voice therapy (Δ = -16.0 [95% CI: -28.7 to -3.2]) and for encounters with Asian patients compared to White patients (Δ = -11.6 [95% CI: -18.9 to -4.2]). Patient and provider satisfaction scores were weakly correlated (r = 0.19).

Conclusions

Our findings suggest that virtual voice therapy is not simply an alternative to in-person service, but rather an effective method useful beyond the current pandemic with proper diagnosis and technical support.

Key words: Telemedicine—Telepractice—Voice therapy—COVID-19—Satisfaction

Abbreviations: TSQ, telemedicine satisfaction questionnaire; USC, University of Southern California; VAS, visual analog scale

INTRODUCTION

Telemedicine involves the use of technology for the communication and delivery of healthcare. Prior to the emergence of COVID-19, telemedicine had already been established as a reliable and important alternative to in-person services during natural disasters and public health emergencies.1 Given the high transmissibility of COVID-19 and its rapid evolution into a pandemic that put significant strain on all available healthcare resources, the Centers for Disease Control (CDC) released a statement in April 2020 encouraging the limitation of all non-essential in-person care.2 Thus, healthcare systems began to rely increasingly on telemedicine for non-emergent services; it offered the opportunity to reduce COVID-19 transmission and conserve limited personal protective equipment while still providing the care that patients require.3, 4, 5, 6, 7 It was strongly recommended to utilize telemedicine for voice therapy in particular, given the high-risk nature of any respiratory tract complaint.8 , 9

The use of telemedicine during the ongoing pandemic has yielded good clinical outcomes and evidence that telemedicine platforms are easy to adopt for both patients and providers within all fields of medicine.10 Telemedicine platforms are well supported by robust technological infrastructure,11 even in rural areas that usually suffer from limited access to in-person care.5 Within the field of otolaryngology, patients report high levels of satisfaction with telemedicine care.12, 13, 14, 15 A recent study performed at this institution demonstrated high concordance rates in both diagnosis and management between initial telemedicine visit and subsequent laryngoscopy findings obtained at an in-person visit16; thus, although laryngoscopy is ultimately needed for definitive diagnosis of vocal pathologies, empiric voice therapy can be offered via telepractice in certain situations until in-person evaluation is safely performed.

Patient satisfaction with in-person voice therapy is generally high,17 , 18 but patient adherence to therapy is limited. Numerous studies report rates of dropout up to 40%,19, 20, 21, 22 with distance to therapy cited as one of the main reasons for lack of follow-up.22 There is significant evidence that virtual voice therapy provides comparable outcomes to in-person sessions,23, 24, 25, 26, 27, 28, 29 with telepractice allowing increased access to care for patients who may be geographically restricted.30 Furthermore, several studies report that patients actually prefer virtual therapy over in-person sessions, citing decreased travel time as a noted benefit.20 , 31 However, to our knowledge, there are currently no studies simultaneously investigating both patient and provider satisfaction in the provision of voice therapy via telepractice. Insight from both perspectives can help improve the care offered to patients and is critical to help direct future applications of virtual voice therapy. The aims of the current study included: (1) to determine and compare patient and provider satisfaction with voice therapy delivered via telepractice during the COVID-19 pandemic, and (2) to identify correlations between levels of satisfaction and patient demographic factors.

MATERIALS AND METHODS

This study was conducted under the University of Southern California (USC) Institutional Review Board approval (HS-20-02853) and adhered to the tenets of the Declaration of Helsinki.

Participants

Participants included adult patients (18 years or older) with a diagnosis of dysphonia who underwent more than one session of voice therapy delivered via telepractice at the USC Voice Center during the COVID-19 pandemic between April and October of 2020. Inclusion criteria required no disclosed cognitive impediment to participate in behavioral therapy delivered via telepractice as well as the ability to read and write in English. Patients received services from one of three speech-language pathologists specializing in voice disorders working at the USC Voice Center at the time. All three speech-language pathologists were female, aged between 27 and 40, and had completed a one year fellowship specializing in the diagnosis and treatment of voice disorders with at least one year of prior clinical experience.

Demographic Data Collection and Diagnosis Classification

Demographic data collected included age, gender, race/ethnicity, insurance type, level of education, income, employment, and length of commute to clinic's physical location in minutes. A chart review was conducted to obtain an initial diagnosis as well as any change in diagnosis following laryngeal imaging. Patient dysphonia diagnoses were classified as (1) hyperfunctional (including phonotrauma, scar/sulcus, muscle tension dysphonia, spasmodic dysphonia, laryngospasm, and vocal process granuloma), (2) hypofunctional (including vocal fold atrophy, presbyphonia, unilateral vocal fold paralysis, and unilateral vocal fold paresis), or (3) other (including tremor, malignant vocal fold lesion, paradoxical vocal fold motion, throat clearing, throat pain, chronic laryngitis, postnasal drip, globus sensation, chronic cough, hyodynia, and dyspnea). Scar/sulcus, spasmodic dysphonia, and vocal process granuloma were categorized as hyperfunctional diagnoses because primary goals for treatment targeted secondary maladaptive muscle tension dysphonia for those particular patients.

Patient and Provider Satisfaction Surveys

Satisfaction surveys were completed by both patients and providers at the conclusion of the second therapy session; satisfaction surveys were not completed during any subsequent encounters. Patients and providers self-reported their level of satisfaction on a visual analog scale (VAS; range 0-100) with end anchors indicating 'not at all satisfied' or 'extremely satisfied'. Patient satisfaction was additionally measured using the Telemedicine Satisfaction Questionnaire (TSQ; range 1-5), a patient-reported outcome measure that has been shown to be both reliable and valid,32 Used in numerous studies investigating patient satisfaction with telemedicine,15 , 33, 34, 35, 36, 37, 38, 39, 40, 41 the TSQ consists of 14 items scored on a 5 point Likert scale and assesses satisfaction across the quality of care provided, similarity to face-to-face encounter, and overall perception of the interaction. Patients also answered two binary questions about (1) their desire to choose telemedicine over in-person therapy in the future and (2) their internet reliability.

Statistical Analysis

Mean VAS provider satisfaction score (range 0-100) was estimated using a linear mixed-effects model. A random effect at the provider level was included to model provider-level deviation from the overall score and to account for clinician's rating encounters with multiple patients. Results from self-reported satisfaction scores obtained with the use of a VAS for providers and patients (range 0-100) were additionally reported using descriptive measures including means and standard deviations.

Two-way scatter plots were used to graphically explore the correlation between provider and patient satisfaction. Pearson r correlations were calculated to measure the degree of correlation between (1) VAS provider and VAS patient satisfaction scores, (2) VAS provider and TSQ patient satisfaction scores, and (3) VAS and TSQ patient satisfaction scores. Pearson r correlation coefficients were interpreted based on previous literature (≤ 0.35: weak correlations, 0.36-0.67: moderate correlations, 0.68-1.0: strong correlations).42

Univariable and multivariable mixed effect models were used to explore factors associated with the VAS provider satisfaction scores. Linear regression models were used to explore factors associated with the VAS patient satisfaction scores. Logistic regression models were used to explore factors associated with the patients’ preference of choosing telemedicine for future visits. All analyses were conducted using Stata 16 (StataCorp, College Station, Texas). Significance was set at P < 0.05, two-tailed.

RESULTS

Patient and Provider Satisfaction

Our study cohort included 226 patients who completed one or more voice therapy sessions via telemedicine during the study period at a tertiary care center. Three speech-language pathologists rated provider satisfaction for all 226 patients. Patient satisfaction survey was completed by 55 patients (24.3%). The majority of patients were diagnosed with hyperfunctional disorders on the basis of prior laryngeal imaging. Detailed demographic and diagnostic information can be found in Table 1 .

TABLE 1.

Summary of Patient Characteristics of Study Cohort (n = 226) and Subgroups of Patients Who Completed Satisfaction Questionnaire (n = 55)

Total Patients Who Completed Satisfaction Questionnaire
N = 226 N = 55
Age, mean (SD) 48.1 (17.3) 47.9 (17.6)
Gender, n (%)
 Male 90 (29.8) 16 (29.1)
 Female 134 (59.2) 37 (67.3)
 Transgender female 1 (0.4) 1 (1.8)
 Nonbinary 1 (0.4) 1 (1.8)
Race/Ethnicity, n (%)
 White 136 (60.2) 34 (61.2)
 Black 21 (9.3) 4 (7.3)
 Hispanic 14 (6.2) 5 (9.1)
 Asian 32 (14.2) 8 (14.5)
 Others or unknown 23 (10.2) 4 (7.3)
Insurance, n (%)
 Private insurance 160 (70.8) 39 (70.9)
 Nonprivate insurance (medicare/medi-cal/worker's comp) 66 (29.2) 16 (29.1)
Provider
 1 13 (5.8) 1 (1.8)
 2 114 (50.4) 31 (56.4)
 3 99 (43.8) 23 (41.8)
Diagnosis
 Hyperfunctional 135 (59.7) 32 (58.2)
 Hypofunctional 53 (23.5) 14 (25.5)
 Others 38 (16.8) 9 (16.4)
Diagnosis changed?* (yes) 9 (4.0) 4 (7.3)
Laryngeal imaging? (yes) 198 (87.6) 43 (78.2)
At least 1 in-person session? (yes) 67 (29.7) 16 (29.1)
Education (n=55) n/a
 High school or less 6 (10.9)
 College/university 27 (49.1)
 Graduate school 22 (40.0)
Income (n=55) n/a
 <$45,000 9 (16.4)
 $45,000-100,000 19 (34.5)
 >$100,000 23 (41.8)
 Unknown or refused 4 (7.3)
Employment (n=55) n/a
 Currently working 28 (50.9)
 Unemployed or currently not working 26 (47.3)
 Unknown or refused 1 (1.8)
Commute to clinic (min), mean (SD) (n=55) n/a 28.1 (24.6)
Internet reliable? (n=55) n/a 49 (89.1)
Choose telemedicine again? (n=55) n/a 40 (72.7)

Patients whose initial diagnosis at presentation was changed after receiving laryngeal imaging.

Laryngeal imaging available prior to voice therapy?

Abbreviations: min, minutes; SD, standard deviation.

Mean (SD) VAS satisfaction scores (range 0-100) for telemedicine voice therapy sessions were high at 86.8 (18.6) for patients and 80.6 (19.7) for providers (Figure 1 A). Mean VAS provider satisfaction scores were additionally estimated using a mixed effect model to account for a random effect at the provider level to be at 79.5 [95% CI: 67.5-91.5]. The mean TSQ score (SD) (range 1-5) rated by the subset of the cohort who completed the patient satisfaction survey (n = 55) was 4.4 (0.6) (Figure 1B). Correlations between provider and patient satisfaction scores were weakly positive for both VAS patient satisfaction scores (Figure 2 A; r = 0.19) and TSQ patient scores (Figure 2B; r = 0.11). Correlation between VAS patient satisfaction and TSQ patient scores was strongly positive (Figure 2C; r = 0.82).

FIGURE 1.

FIGURE 1

Boxplots summarizing patient and provider satisfaction. (A) Patient and provider satisfaction measured on a Visual Analog Scale (score range: 0 - 100). (B) Patient satisfaction measured on the Telemedicine Satisfaction Questionnaire (TSQ) (score range: 1 - 5). Mean TSQ is an average score for all 14 questions, domain 1 queries quality of care provided, domain 2 queries the similarity to a face-to-face encounter, and domain 3 queries the overall perception of the interaction. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

FIGURE 2.

FIGURE 2

(A) Correlation between provider and patient satisfaction quantified on Visual Analog Scale (VAS; r = 0.19). (B) Correlation between provider and patient satisfaction quantified on Telemedicine Satisfaction Questionnaire (TSQ; r = 0.11). (C) Correlation between VAS patient satisfaction and TSQ patient score (r = 0.82). (≤ 0.35: weak correlations, 0.36-0.67: moderate correlations, 0.68-1.0: strong correlations). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Factors Associated with Provider Satisfaction

Univariable and multivariable linear mixed effects models were used to examine factors associated with provider satisfaction (Table 2 ). Provider satisfaction was significantly lower in voice therapy sessions with Asian patients than in those with White patients (Δ= -11.6, 95% CI: [-18.9 to -4.2]), for patients whose diagnoses changed after initiation of voice therapy as compared to those whose diagnoses remained unchanged (Δ= -16.0, 95% CI: [-28.7 to -3.2]), and for patients who did not have a laryngeal exam prior to initiation of voice therapy compared to those who did (Δ=8.1, 95% CI: [0.4 - 15.8]). Provider satisfaction was significantly higher for patients diagnosed with hyperfunctional diagnoses as compared to those diagnosed with other (nonhyperfunctional and nonhypofunctional) (Δ=-7.5, 95% CI: [-14.4 to -0.5]). Upon multivariable analysis, provider satisfaction scores remained significantly lower for sessions with Asian patients and for patients whose diagnoses changed following initiation of voice therapy (Table 2).

TABLE 2.

Univariable and Multivariable Linear Mixed Effect Models Exploring Factors Associated With Provider Satisfaction

Univariable Multivariable
b-Coeff P-Value b-Coeff P-Value
Age 0.02 [-0.1 - 0.2] 0.767 0.02 [-0.2 - 0.2] 0.862
Gender
 Male Ref ref
 Female -0.6 [-5.8 - 4.5] 0.805 -0.8 [-5.9 - 4.2] 0.750
 Transgender female -32.9 [-70.9 - 5.2] 0.091 -17.1 [-55.0 - 20.8] 0.376
 Nonbinary 17.3 [-20.8 - 55.3] 0.89 12.3 [-24.4 - 49.1] 0.511
Race
 White ref ref
 Black -6.4 [-15.1 - 2.4] 0.154 -7.5 [-16.1 - 1.2] 0.090
 Hispanic -0.2 [-10.7 - 10.3] 0.970 -1.4 [-11.7 - 8.8] 0.782
 Asian -11.6 [-18.9 - -4.2] 0.002 -11.9 [-19.1 - -4.6] 0.001
 Others or unknown -0.5 [-8.9 - 7.9] 0.905 -0.6 [-8.8 - 7.6] 0.889
Insurance
 Private insurance ref ref
 Non-private insurance -0.2 [-5.8 - 5.4] 0.938 -1.6 [-8.3 - 5.2] 0.652
Diagnosis
 Hyperfunctional ref ref
 Hypofunctional -0.7 [-6.8 - 5.4] 0.831 -0.8 [-6.7 to -11.2] 0.804
 Others -7.5 [-14.4 - -0.5] 0.034 -4.2 [-11.2 - 2.8] 0.238
Diagnosis changed
 No ref ref
 Yes -16.0 [-28.7 - -3.2] 0.014 -15.2 [-28.1 - -2.3] 0.021
Laryngeal imaging
 No ref ref
 Yes 8.1 [0.4 - 15.8] 0.040 4.8 [-2.9 - 12.5] 0.219
In-person visit
 No ref ref
 Yes 1.7 [-3.9 - 7.2] 0.552 -0.5 [-6.0 - 5.1] 0.869

Bolded values are those that reached statistical significance (P<0.05).

Factors Associated with Patient Satisfaction

Factors associated with patient satisfaction scores were explored using linear regression models (Table 3 ). VAS patient satisfaction scores did not differ based on any patient demographic factors, diagnostic classification, or internet reliability. Patients with hypofunctional diagnoses had significantly higher mean TSQ scores as compared to those with hyperfunctional diagnoses (β=0.4, 95% CI: [0.1 - 0.8]).

TABLE 3.

Multivariable Regression Models Exploring Factors Associated With Patient Satisfaction

VAS Patient Satisfaction(range 0-100) TSQ Scores(range 1-5) Likelihood of Choosing Telemedicine Again in the Future(yes/no)
b-Coeff P-Value b-Coeff P-Value b-Coeff P-Value
Age 0.2 [-0.1 - 0.5] 0.132 0.006 [-0.002 - 0.015] 0.153 0.001 [-0.006 - 0.008] 0.746
Gender
 Female (%) -1.8 [-10.6 - 7.1] 0.690 -0.2 [-0.5 - 0.01] 0.06 -0.2 [-0.4 - 0.01] 0.062
Race
 White ref ref ref
 Black 13.1 [-6.3 - 32.4] 0.181 0.3 [-0.3 - 0.9] 0.3 0.4 [-0.1 - 0.8] 0.112
 Hispanic 9.1 [-8.4 - 26.7] 0.301 0.2 [-0.3 - 0.7] 0.5 0.4 [-0.04 - 0.7] 0.08
 Asian -4.7 [-19.1 - 9.7] 0.517 -0.1 [-0.5 - 0.3] 0.7 0.4 [0.02 - 0.7] 0.034
 Others or unknown -13.7 [-33.1 - 5.7] 0.162 -0.4 [-1.0 - 0.2] 0.2 -0.4 [-0.8 - 0.04] 0.075
Insurance
 Private insurance ref ref ref
 Non-private 5.9 [-5.1 - 17.0] 0.285 0.1 [-0.2 - 0.5] 0.439 -0.1 [-0.4 - 0.1] 0.284
Education
 High school or less ref ref ref
 College/university -8.1 [-25.0 - 8.8] 0.342 -0.1 [-0.6 - 0.4] 0.577 -0.2 [-0.6 - 0.2] 0.228
 Graduate school -3.5 [-10.8 - 13.7] 0.684 0.05 [-0.47 - 0.56] 0.860 0.03 [-0.4 - 0.4] 0.881
Income
 <$45,000 ref ref ref
 $45,000-100,000 -0.5 [-16.0 - 14.9] 0.945 -0.01 [-0.47 - 0.45] 0.971 0.2 [-0.2 - 0.5] 0.298
 >$100,000 -3.4 [-18.4 - 11.6] 0.647 0.1 [-0.3 - 0.6] 0.610 0.3 [-0.02 - 0.7] 0.067
 Unknown or refused 2.5 [-20.4 - 15.5] 0.826 -0.1 [-0.8 - 0.6] 0.839 -0.3 [-0.8 - 0.2] 0.238
Employment
 Currently working ref ref ref
 Unemployed or currently not working 3.8 [-6.5 - 14.1] 0.466 0.01 [-0.29 - 0.32] 0.928 -0.2 [-0.4 - 0.03] 0.095
 Unknown or refused 2.0 [-36.4 - 10.5] 0.916 0.6 [-0.5 - 1.7] 0.294 0.2 [-0.7 - 1.1] 0.694
Commute to clinic (min) -0.1 [-0.3 - 0.1] 0.364 -0.003 [-0.009 - 0.003] 0.341 -0.001 [-0.006 - 0.004] 0.596
Provider
 1 ref ref ref
 2 -7.5 [-44.8 - 29.8] 0.687 -0.1 [-1.2 - 1.0] 0.856 -0.3 [-1.2 - 0.6] 0.534
 3 -16.7 [-54.2 - 20.8] 0.376 -0.2 [-1.4 - 0.9] 0.678 -0.3 [-1.2 - 0.7] 0.578
Diagnosis
 Hyperfunctional ref ref ref
 Hypofunctional 8.4 [-3.5 - 20.3] 0.161 0.4 [0.1 - 0.8] 0.011 0.3 [-0.01 - 0.6] 0.06
 Others -2.8 [-16.7 - 11.2] 0.694 -0.1 [-0.5 - 0.3] 0.477 0.01 [-0.3 - 0.3] 0.95
Diagnosis change
 No ref ref ref
 Yes -1.7 [-21.2 - 17.9] 0.866 -0.04 [-0.62 - 0.54] 0.889 -0.2 [-0.7 - 0.2] 0.298
Prior laryngeal imaging
 No ref ref ref
 Yes 8.8 [-3.3 - 20.8] 0.149 0.2 [-0.1 - 0.6] 0.205 0.1 [-0.2 - 0.4] 0.602
In-person voice therapy sessions
 No ref ref ref
 Yes 6.1 [-4.9 - 17.2] 0.271 0.2 [-0.1 - 0.5] 0.248 0.1 [-0.1 - 0.4] 0.373
Internet reliability
 No ref ref ref
 Yes 4.1 [-12.2 - 20.3] 0.618 0.3 [-0.2 - 0.8] 0.190 0.4 [0.1 - 0.8] 0.021

Note: Internet reliability was significantly associated with high likelihood of choosing telemedicine in the future (Odds ratio: 6.90 [1.11-42.86], P = 0.04).

Bolded values are those that reached statistical significance (P<0.05).

Among the 55 participants who completed the patient satisfaction survey, 40 (72.7%) reported that they would choose to do voice therapy via telemedicine, even when safe in-person appointments become available. Patient preference of choosing telemedicine for future visits was significantly higher among patients reporting reliable internet (OR = 6.9, 95% CI: [1.1 - 42.9], P = 0.04) and among Asian patients (β = 0.4, 95% CI: [0.02 - 0.7]) in comparison to White patients.

DISCUSSION

Herein we present patient and provider satisfaction with voice therapy delivered via telepractice during the COVID-19 pandemic at a tertiary care center and its associated factors. Our study evaluated both patient and provider satisfaction for virtual voice therapy simultaneously and additionally identified demographic and clinical factors that were associated with their levels of satisfaction. Overall, both patients and providers were highly satisfied with their telemedicine voice therapy encounters, with over 70% of patients reporting that they would elect to complete voice therapy via telemedicine even when safe in-person appointments become available. These high levels of patient satisfaction are consistent with previous publications highlighting the favorable patient experience with voice therapy delivered via telepractice.23, 24, 25, 26, 27, 28 , 30

Having reliable internet was significantly associated with patients reporting an intent to continue treatment via telemedicine over in-person therapy. Prior studies have described similar findings, with poor audiovisual quality resulting in decreased patient engagement and satisfaction with telemedicine.43, 44, 45 Given the importance of robust technology for a successful telemedicine encounter,11 we argue that having access to reliable internet is crucial for wider implementation of telemedicine in the future. Institutions offering care via telepractice should provide education to support patients with limited digital literacy and financial resources (i.e., tutorials for patients on how to complete a virtual visit, information about free high-speed internet access, etc.). Other previously described disadvantages of telemedicine for patients include a lack of insurance coverage as well as out-of-state service restrictions that are placed on virtual visits.43, 44, 45 In the current study, there were no differences in patient satisfaction based on type of insurance coverage, nor were there any patients included who were prevented from receiving care due to out-of-state residence; however, future studies should explore these barriers further.

Patient satisfaction with telemedicine measured by TSQ was significantly higher for those diagnosed with hypofunctional as compared to hyperfunctional disorders. This may be due to the greater need for manual therapy services, specifically digital laryngeal manipulation and/or manual circumlaryngeal techniques, for patients with hyperfunctional diagnoses; these techniques can be difficult to teach via telemedicine. Anticipating this challenge, we adapted our protocols during the COVID-19 pandemic to develop an informational sheet, guide, and training formats to teach self-administered manual therapy techniques. However, in-person provision as well as hand-on-hand training of this skill may be more suitable for this subgroup of patients as evidenced by their significantly lower satisfaction scores. Another important consideration is that because older patients and those with more involved medical comorbidities have a higher risk of contracting serious illness in the event of COVID-19 infection, these patients may have seen a greater benefit in the provision of services via telepractice than those who are otherwise young and healthy. As the majority of patients with hypofunctional diagnoses (ie. presbyphonia, vocal fold atrophy, vocal fold paralysis or paresis) are either elderly or have significant medical comorbidities, this may have confounded the higher satisfaction seen within this cohort. Future research not subject to potential pandemic confounders should explore the difference between hypofunctional and hyperfunctional patient satisfaction further.

For providers, satisfaction was found to be significantly lower for voice therapy sessions with Asian patients. Interestingly, there was no difference based on race for patient satisfaction; however, Asian patients were significantly more likely than White patients to choose telepractice over in-person care when queried about how they would prefer to seek care in the future. It is important to note that only English-speaking patients were included in this study to control for language differences and/or interpreter usage. Regardless, this does not preclude the possibility that there was still a language barrier experienced between the provider and patient that caused the provider to be less satisfied with the visit—if English was not the patient's first language or if the patient spoke with an accent, for example. Unfortunately, we are unable to assess if the lower provider satisfaction seen for encounters with Asian patients is related to the telepractice modality or to the experience of providing voice therapy itself as we do not have matched in-person visit satisfaction scores for comparison. From the patient perspective, previous studies have shown that Asians generally demonstrate high levels of satisfaction with telemedicine.46 However, Asian patients, in particular, have expressed concern that virtual healthcare relies on patients’ own abilities to monitor and manage their health conditions.47 As the patient generally accepts less authority within patient-provider relationships in many Asian cultures, this highlights the need for culturally sensitive care. Future efforts to address potential disparities in providing voice therapy for racial minorities should be explored.

Our findings also revealed that provider satisfaction was significantly lower for patients whose diagnoses changed following the initiation of voice therapy. These diagnoses changed because patients obtained laryngeal imaging between voice therapy visits, due to limitations placed by the COVID-19 pandemic, which altered their original diagnoses. It follows that clinicians have greater confidence with the plan of care when developed and supported based on pathology visualized via laryngeal imaging. This highlights the importance of following best practice guidelines in the treatment of patients with dysphonia, which recommend obtaining laryngeal imaging prior to initiating voice therapy.48

Lastly, only a weak positive correlation was found between provider and patient satisfaction scores. This may be explained by a difference in criteria between patients and providers used to determine subjective satisfaction with telemedicine. For example, clinicians may base their satisfaction scores on how successfully they were able to explore various therapy techniques with patients to achieve their goals, while patients may base their satisfaction scores on how convenient the telemedicine therapy was or how well they connected with a certain provider. Furthermore, while different aspects of patient satisfaction were explored using various questionnaires, provider satisfaction was assessed using one question rated on a VAS as there is no validated questionnaire for provider satisfaction with telemedicine encounters. Given the increasing reliance on telemedicine inspired by the COVID-19 pandemic, we advocate that a questionnaire for clinicians should be developed.

Acknowledging the higher rates of patient dropout that are traditionally seen with in-person voice therapy,19, 20, 21, 22 this study was intentionally designed to include patients who attended at least two sessions of virtual voice therapy. Although this study did not explore duration of patient attendance to virtual voice therapy, this would be important to investigate in the future. Patients previously have reported the distance of travel to their voice therapy appointments as rationale for dropout22; virtual voice therapy offers a solution to this.

There are several limitations in this study. Although provider satisfaction surveys were filled out for 226 patient encounters, only 55 (25%) patients completed patient satisfaction surveys. Our reliance on patients and providers to self-report their levels of satisfaction means that recall and participation bias are important factors to consider. This study is also limited in that our study cohort comes from a single tertiary care center with three specialized speech-language pathologists in a large urban setting with a high risk of COVID-19 exposure and infection. Therefore, our results may not be generalizable (1) to other voice centers that exist in different healthcare settings or geopolitical locations and (2) outside of the COVID-19 pandemic. Furthermore, it is possible that providers suffered burnout from providing therapy solely via a screen towards the latter months of the study period, but also likely that their increased experience with virtual appointments provided increased satisfaction over time; these may be confounding factors with competing effects for provider satisfaction. The current study examined provider satisfaction during the early period of the COVID-19 pandemic. Future follow-up studies are needed to assess changes in provider satisfaction with telemedicine asas they gain more experience with providing virtual care;this information is crucial to better understand the utility of telemedicine voice therapy beyond the pandemic. Despite these limitations, our study is a valuable first assessment of patient and provider satisfaction with virtual voice therapy.

CONCLUSION

Virtual voice therapy has previously been shown to have comparable outcomes to in-person therapy with high levels of patient satisfaction.23, 24, 25, 26, 27, 28 , 30 The current study evaluated both provider and patient satisfaction with voice therapy delivered via telepractice during the COVID-19 pandemic. Both patients and providers reported overall high levels of satisfaction, with the majority of patients preferring telemedicine over in-person therapy especially when they had reliable internet connection. Our findings further support that telepractice is a viable and beneficial method for delivering voice therapy services, not simply an alternative to in-person service provision.

REFERENCES

  • 1.Lurie N, Carr BG. The role of telehealth in the medical response to disasters. JAMA Intern Med. 2018;178:745–746. doi: 10.1001/jamainternmed.2018.1314. [DOI] [PubMed] [Google Scholar]
  • 2.Activities CDC . Centers for Disease Control and Prevention; Atlanta: 2020. Initiatives Supporting the COVID-19 Response and the President's Plan for Opening America Up Again. [Google Scholar]
  • 3.Colbert GB, Venegas-Vera AV, Lerma EV. Utility of telemedicine in the COVID-19 era. Rev Cardiovasc Med. 2020;21:583–587. doi: 10.31083/j.rcm.2020.04.188. [DOI] [PubMed] [Google Scholar]
  • 4.Cervino G, Oteri G. COVID-19 Pandemic and Telephone Triage before Attending Medical Office: Problem or Opportunity?. Medicina2020;56(5):250. [DOI] [PMC free article] [PubMed]
  • 5.Koraishy FM, Rohatgi R. Telenephrology: an emerging platform for delivering renal health care. Am J Kidney Dis. 2020;76(3):417–426. doi: 10.1053/j.ajkd.2020.02.442. [DOI] [PubMed] [Google Scholar]
  • 6.Salzano A, D'Assante R, Stagnaro FM, et al. Heart failure management during COVID-19 outbreak in Italy. Telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail. 2020;22(6):1048–1050. doi: 10.1002/ejhf.1911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hincapié MA, Gallego JC, Gempeler A, et al. Implementation and usefulness of telemedicine during the COVID-19 pandemic: a scoping review. J Primary Care Commun Health. 2020;11 doi: 10.1177/2150132720980612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Doll EJ, Braden MN, Thibeault SL. COVID-19 and speech-language pathology clinical practice of voice and upper airway disorders. Am J Speech Lang Pathol. 2021;30:63–74. doi: 10.1044/2020_AJSLP-20-00228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Castillo-Allendes A, Contreras-Ruston F, Cantor-Cutiva LC, et al. Voice therapy in the context of the COVID-19 pandemic: guidelines for clinical practice. J Voice. 2021;35:717–727. doi: 10.1016/j.jvoice.2020.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bashshur R, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 Pandemic, Lessons for the Future. Telemed J E Health. 2020;26(5):571–573 [DOI] [PubMed]
  • 11.Ting DSW, Carin L, Dzau V, et al. Digital technology and COVID-19. Nat Med. 2020;26:459–461. doi: 10.1038/s41591-020-0824-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Fieux M, Duret S, Bawazeer N, et al. Telemedicine for ENT: effect on quality of care during Covid-19 pandemic. Euro Ann Otorhinolaryngol, Head Neck Dis. 2020;137:257–261. doi: 10.1016/j.anorl.2020.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ning AY, Cabrera CI, D'Anza B. Telemedicine in otolaryngology: a systematic review of image quality, diagnostic concordance, and patient and provider satisfaction. Ann Otol, Rhinol Laryngol. 2021;130:195–204. doi: 10.1177/0003489420939590. [DOI] [PubMed] [Google Scholar]
  • 14.Regina Molini-Avejonas D, Rondon-Melo S, de La Higuera Amato CA, et al. A systematic review of the use of telehealth in speech, language and hearing sciences. J Telemed Telecare. 2015;21:367–376. doi: 10.1177/1357633X15583215. [DOI] [PubMed] [Google Scholar]
  • 15.Choi JS, Kim JH, Park S, et al. Telemedicine in otolaryngology during COVID-19: patient and physician satisfaction. Otolaryngol–Head Neck Surg. 2021;167(1):56–64. doi: 10.1177/01945998211041921. [DOI] [PubMed] [Google Scholar]
  • 16.Choi JS, Yin V, Wu F, et al. Utility of telemedicine for diagnosis and management of laryngology-related complaints during COVID-19. Laryngoscope. 2022;132(4):831–837. doi: 10.1002/lary.29838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Braden MN, van Leer E, McConville K, et al. Patient, parent, and speech-language pathologists' perceptions of pediatric voice therapy through interviews. Am J Speech Lang Pathol. 2018;27:1385–1404. doi: 10.1044/2018_AJSLP-17-0226. [DOI] [PubMed] [Google Scholar]
  • 18.Ziegler A, Dastolfo C, Hersan R, et al. Perceptions of voice therapy from patients diagnosed with primary muscle tension dysphonia and benign mid-membranous vocal fold lesions. J Voice. 2014;28:742–752. doi: 10.1016/j.jvoice.2014.02.007. [DOI] [PubMed] [Google Scholar]
  • 19.MacKenzie K, Millar A, Wilson JA, et al. Is voice therapy an effective treatment for dysphonia? A randomised controlled trial. BMJ. 2001;323(7314):658. doi: 10.1136/bmj.323.7314.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hapner E, Portone-Maira C, Johns Iii MM. A study of voice therapy dropout. J Voice. 2009;23:337–340. doi: 10.1016/j.jvoice.2007.10.009. [DOI] [PubMed] [Google Scholar]
  • 21.Ahn CM, Shin IS, Shin JE. The study of satisfaction of voice therapy in patients with voice disorders. J Korean Soc Laryngol, Phoniatrics Logopedics. 2016;27:35–39. [Google Scholar]
  • 22.Portone C, Johns Iii MM, Hapner ER. A review of patient adherence to the recommendation for voice therapy. J Voice. 2008;22:192–196. doi: 10.1016/j.jvoice.2006.09.009. [DOI] [PubMed] [Google Scholar]
  • 23.Duffy JR, Werven GW, Aronson AE. Telemedicine and the diagnosis of speech and language disorders. Mayo Clin Proc. 1997;72(12):1116–1122. [DOI] [PubMed]
  • 24.Mashima PA, Birkmire-Peters DP, Syms MJ, et al. 2003
  • 25.Rangarathnam B, Gilroy H, McCullough GH. Do patients treated for voice therapy with telepractice show similar changes in voice outcome measures as patients treated face-to-face. EBP Briefs. 2016;11:1–6. [Google Scholar]
  • 26.Becker DR, Gillespie AI. In the Zoom Where It Happened: Telepractice and the Voice Clinic in 2020. Semin Speech Lang. 2021;42(1):64–72. [DOI] [PubMed]
  • 27.Weidner K, Lowman J. Telepractice for adult speech-language pathology services: a systematic review. Perspect ASHA Spec Interest Groups. 2020;5:326–338. [Google Scholar]
  • 28.Kelchner L. Telehealth and the treatment of voice disorders: a discussion regarding evidence. Perspect Voice Voice Disorders. 2013;23(3):88–94. [Google Scholar]
  • 29.Gray R, Michael D, Hoffmeister J, et al. Patient satisfaction with virtual vs in-person voice therapy. J Voice. 2022 doi: 10.1016/j.jvoice.2022.03.011. S0892-1997(22)00081-9. [DOI] [PubMed] [Google Scholar]
  • 30.Mashima PA, Brown JE. Remote management of voice and swallowing disorders. Otolaryngol Clin North Am. 2011;44:1305–1316. doi: 10.1016/j.otc.2011.08.007. [DOI] [PubMed] [Google Scholar]
  • 31.Tenforde AS, Borgstrom H, Polich G, et al. Outpatient physical, occupational, and speech therapy synchronous telemedicine: a survey study of patient satisfaction with virtual visits during the COVID-19 pandemic. Am J Phys Med Rehabil. 2020;99(11):977–981. doi: 10.1097/PHM.0000000000001571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Yip MP, Chang AM, Chan J, et al. Development of the telemedicine satisfaction questionnaire to evaluate patient satisfaction with telemedicine: a preliminary study. J Telemed Telecare. 2003;9:46–50. doi: 10.1258/135763303321159693. [DOI] [PubMed] [Google Scholar]
  • 33.Yip MP, Mackenzie A, Chan J. Patient satisfaction with telediabetes education in Hong Kong. J Telemed Telecare. 2002;8:48–51. doi: 10.1258/1357633021937460. [DOI] [PubMed] [Google Scholar]
  • 34.Hajesmaeel-Gohari S, Bahaadinbeigy K. The most used questionnaires for evaluating telemedicine services. BMC Med Inf Decis Making. 2021;21:1–11. doi: 10.1186/s12911-021-01407-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mauro E, Marciano S, Torres MC, et al. Telemedicine improves access to hepatology consultation with high patient satisfaction. J Clin Exp Hepatol. 2020;10:555–562. doi: 10.1016/j.jceh.2020.04.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Le LB, Rahal HK, Viramontes MR, et al. Patient satisfaction and healthcare utilization using telemedicine in liver transplant recipients. Dig Dis Sci. 2019;64:1150–1157. doi: 10.1007/s10620-018-5397-5. [DOI] [PubMed] [Google Scholar]
  • 37.Pakanati V, Raol N, Siong TC, et al. Patient and physician satisfaction with telemedicine in pediatric otolaryngology. Int J Pediatr Otorhinolaryngol. 2022;156 doi: 10.1016/j.ijporl.2022.111097. [DOI] [PubMed] [Google Scholar]
  • 38.Bell S, Karamchandani U, Malcolmson K, et al. Acceptability of telegenetics for families with genetic eye diseases. Genes. 2021;12:276. doi: 10.3390/genes12020276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wright E, Shaltout O, Zokvic MA, et al. Delivery of menopause care during a pandemic: an evaluation of patient satisfaction with telephone visits. Menopause (New York, NY) 2022;29:184. doi: 10.1097/GME.0000000000001906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Guille C, Johnson E, Douglas E, et al. A pilot study examining access to and satisfaction with maternal mental health and substance use disorder treatment via telemedicine. Telemed Rep. 2022;3:24–29. doi: 10.1089/tmr.2021.0041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nair PP, Aghoram R, Thomas B, et al. Video teleconsultation services for persons with epilepsy during COVID-19 pandemic: an exploratory study from public tertiary care hospital in Southern India on feasibility, satisfaction, and effectiveness. Epilepsy Behav. 2021;117 doi: 10.1016/j.yebeh.2021.107863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Taylor R. Interpretation of the correlation coefficient: a basic review. J Diagn Med Sonogr. 1990;6:35–39. doi: 10.1177/875647939000600106. [DOI] [Google Scholar]
  • 43.Bokolo AJ. Exploring the adoption of telemedicine and virtual software for care of outpatients during and after COVID-19 pandemic. Irish J Med Sci (1971-) 2021;190:1–10. doi: 10.1007/s11845-020-02299-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cantarella G, Barillari MR, Lechien JR, et al. The challenge of virtual voice therapy during the COVID-19 pandemic. J Voice. 2021;35:336–337. doi: 10.1016/j.jvoice.2020.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zughni LA, Gillespie AI, Hatcher JL, et al. Telemedicine and the interdisciplinary clinic model: during the COVID-19 pandemic and beyond. Otolaryngol–Head Neck Surg. 2020;163:673–675. doi: 10.1177/0194599820932167. [DOI] [PubMed] [Google Scholar]
  • 46.Allen AZ, Zhu D, Shin C, et al. Patient satisfaction with telephone versus video-televisits: a cross-sectional survey of an Urban, Multiethnic Population. Urology. 2021;156:110–116. doi: 10.1016/j.urology.2021.05.096. [DOI] [PubMed] [Google Scholar]
  • 47.Nguyen M-LT, Garcia F, Juarez J, et al. Satisfaction can co-exist with hesitation: qualitative analysis of acceptability of telemedicine among multi-lingual patients in a safety-net healthcare system during the COVID-19 pandemic. BMC Health Services Res. 2022;22:1–9. doi: 10.1186/s12913-022-07547-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Stachler RJ, Francis DO, Schwartz SR, et al. Clinical practice guideline: hoarseness (dysphonia)(update) Otolaryngol–Head Neck Surg. 2018;158(1_suppl):S1–S42. doi: 10.1177/0194599817751030. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Voice are provided here courtesy of Elsevier

RESOURCES